Skip to main content
Journal cover image

Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.

Publication ,  Journal Article
Friedman, HS; Pegg, AE; Johnson, SP; Loktionova, NA; Dolan, ME; Modrich, P; Moschel, RC; Struck, R; Brent, TP; Ludeman, S; Bullock, N; Keir, S ...
Published in: Cancer Chemother Pharmacol
1999

PURPOSE: The human medulloblastoma cell line D283 Med (4-HCR), a line resistant to 4-hydroperoxycyclophosphamide (4-HC), displays enhanced repair of DNA interstrand crosslinks induced by phosphoramide mustard. D283 Med (4-HCR) cells are cross-resistant to 1,3-bis(2-chloroethyl)- -nitrosourea, but partial sensitivity is restored after elevated levels of O6-alkylguanine-DNA alkyltransferase (AGT) are depleted by O6-benzylguanine (O6-BG). Studies were conducted to define the activity of 4-HC and 4-hydroperoxydidechlorocyclophosphamide against D283 Med (4-HCR) after AGT is depleted by O6-BG. METHODS: Limiting dilution and xenograft studies were conducted to define the activity of 4-HC and 4-hydroperoxydidechlorocyclophosphamide with or without O6-BG. RESULTS: The activity of 4-HC and 4-hydroperoxydidechlorocyclophosphamide against D283 Med (4-HCR) was increased after AGT depletion by O6-BG preincubation. Similar studies with Chinese hamster ovary cells, with or without stable transfection with a plasmid expressing the human AGT protein, revealed that the AGT-expressing cells were significantly less sensitive to 4-HC and 4-hydroperoxydidechlorocyclophosphamide. Reaction of DNA with 4-HC, phosphoramide mustard, or acrolein revealed that only 4-HC and acrolein caused a decrease in AGT levels. CONCLUSIONS: We propose that a small but potentially significant part of the cellular toxicity of cyclophosphamide in these cells is due to acrolein, and that this toxicity is abrogated by removal of the acrolein adduct from DNA by AGT.

Duke Scholars

Published In

Cancer Chemother Pharmacol

DOI

ISSN

0344-5704

Publication Date

1999

Volume

43

Issue

1

Start / End Page

80 / 85

Location

Germany

Related Subject Headings

  • Tumor Cells, Cultured
  • Transplantation, Heterologous
  • Transfection
  • Oncology & Carcinogenesis
  • O(6)-Methylguanine-DNA Methyltransferase
  • Neoplasm Transplantation
  • Mice, Nude
  • Mice
  • Medulloblastoma
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Friedman, H. S., Pegg, A. E., Johnson, S. P., Loktionova, N. A., Dolan, M. E., Modrich, P., … Colvin, O. M. (1999). Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase. Cancer Chemother Pharmacol, 43(1), 80–85. https://doi.org/10.1007/s002800050866
Friedman, H. S., A. E. Pegg, S. P. Johnson, N. A. Loktionova, M. E. Dolan, P. Modrich, R. C. Moschel, et al. “Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.Cancer Chemother Pharmacol 43, no. 1 (1999): 80–85. https://doi.org/10.1007/s002800050866.
Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, et al. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase. Cancer Chemother Pharmacol. 1999;43(1):80–5.
Friedman, H. S., et al. “Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.Cancer Chemother Pharmacol, vol. 43, no. 1, 1999, pp. 80–85. Pubmed, doi:10.1007/s002800050866.
Friedman HS, Pegg AE, Johnson SP, Loktionova NA, Dolan ME, Modrich P, Moschel RC, Struck R, Brent TP, Ludeman S, Bullock N, Kilborn C, Keir S, Dong Q, Bigner DD, Colvin OM. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase. Cancer Chemother Pharmacol. 1999;43(1):80–85.
Journal cover image

Published In

Cancer Chemother Pharmacol

DOI

ISSN

0344-5704

Publication Date

1999

Volume

43

Issue

1

Start / End Page

80 / 85

Location

Germany

Related Subject Headings

  • Tumor Cells, Cultured
  • Transplantation, Heterologous
  • Transfection
  • Oncology & Carcinogenesis
  • O(6)-Methylguanine-DNA Methyltransferase
  • Neoplasm Transplantation
  • Mice, Nude
  • Mice
  • Medulloblastoma
  • Male